CorMedix Inc. (NASDAQ:CRMD) closed Wednesday at $3.99 per share, up from $3.90 a day earlier. While CorMedix Inc. has overperformed by 2.31%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CRMD fell by -22.07%, with highs and lows ranging from $8.02 to $2.64, whereas the simple moving average jumped by 1.22% in the last 200 days.
Do You Own These 7 Inflation-Survival Stocks?
Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.
Click here to get your free copy of the report
On February 17, 2021, Needham started tracking CorMedix Inc. (NASDAQ: CRMD) recommending Buy. A report published by JMP Securities on September 29, 2020, Initiated its previous ‘Mkt Outperform’ rating for CRMD. Truist also rated CRMD shares as ‘Buy’, setting a target price of $20 on the company’s shares in an initiating report dated September 21, 2020. B. Riley FBR Initiated an Buy rating on December 18, 2019, and assigned a price target of $48. H.C. Wainwright resumed its ‘Buy’ rating for CRMD, as published in its report on March 26, 2019. ROTH Capital’s report from December 06, 2018 suggests a price prediction of $6 for CRMD shares, giving the stock a ‘Buy’ rating. H.C. Wainwright also rated the stock as ‘Buy’.
Analysis of CorMedix Inc. (CRMD)
Further, the quarter-over-quarter decrease in sales is -82.10%, showing a negative trend in the upcoming months.
There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of CorMedix Inc.’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of -48.70% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 11.80, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
As an indicator of volatility for any stock, average volume can also be very valuable, and CRMD is recording an average volume of 194.12K. On a monthly basis, the volatility of the stock is set at 7.93%, whereas on a weekly basis, it is put at 7.28%, with a gain of 7.84% over the past seven days. Furthermore, long-term investors anticipate a median target price of $15.00, showing growth from the present price of $3.99, which can serve as yet another indication of whether CRMD is worth investing in or should be passed over.
How Do You Analyze CorMedix Inc. Shares?
Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.90%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 26.80% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in CRMD shares?
The recent increase in stakes in CRMD appears to be a result of several institutional investors and hedge funds increasing their positions. Nomura Securities Co., Ltd.’s position in CRMD has increased by 0.01% in the first quarter. The company now owns 2,952,334 shares of the stock, with a value of $9.06 million, following the purchase of 207 additional shares during the last quarter. The Vanguard Group, Inc. made another increased to its shares in CRMD during the first quarter, upping its stake by 8.63%.
At the end of the first quarter, Millennium Management LLC decreased its CRMD holdings by -17.05% and now holds 0.57 million CRMD shares valued at $1.75 million with the lessened -0.12 million shares during the period. CRMD shares are owned by institutional investors to the tune of 26.80% at present.